Interim data suggest major response with darbepoetin in anemic MDS patients.
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D017322:Clinical Trials, Phase II as Topic; D000068256:Darbepoetin alfa; D016208:Databases, Factual; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005221:Fatigue / Q000209:etiology / Q000517:prevention & control; D006454:Hemoglobins / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000150:complications*
D006454:Hemoglobins; D004921:Erythropoietin; D000068256:Darbepoetin alfa